🇺🇸 FDA
Pipeline program

Intra-arterial thrombolysis

2025.8.10V1.0

Phase 3 other active

Quick answer

Intra-arterial thrombolysis for Acute Ischemic Stroke is a Phase 3 program (other) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Acute Ischemic Stroke
Phase
Phase 3
Modality
other
Status
active

Clinical trials